在患有渐进性家族性肝内胆固醇症患者的奥德维克西巴特治疗的实用考虑:单中心病例系列
Milena Marx1, Steffen Hartleif1, Johannes Hilberath1
1Pediatric Gastroenterology and Hepatology, University Children's Hospital Tübingen, Hoppe-Seyler Str. 1, 72076 Tübingen, Germany.
Journal of clinical medicine
|January 8, 2025
概括
在大多数患有进展性家族性肝内胆固醇症 (PFIC) 的患者中,奥德维克西巴特改善了和睡眠等症状. 然而,完全失去胆盐出口 (BSEP) 蛋白质的患者并不总是受益,需要监测.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 儿科胃肠病学 儿科胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 渐进性家族性肝内胆固醇症 (PFIC) 导致严重的和其它胆固醇症症状.
- 奥德维克西巴特 (Odevixibat) 是一种胆酸输送抑制剂,已被批准用于欧盟的PFIC治疗,并在美国的PFIC治疗.
- 关于奥德维克西巴特在PFIC患者中的有效性和安全性的现实数据有限.
研究的目的:
- 评估奥德维克西巴特在PFIC患者中的实际有效性和安全性.
- 为了描述不同 PFIC 亚型的治疗结果.
- 为了确定治疗反应的潜在预测因素.
主要方法:
- 回顾9名PFIC患者在一个中心接受奥德维克西巴特治疗的病例系列.
- 通过病例报告表格收集的数据,包括临床和实验室参数.
- 分析与,肝功能,睡眠和不良事件相关的结果.
主要成果:
- 在9名患者中,有5名患者 (PFIC1,n=2;PFIC2,n=7) 血清胆酸,,肝检测和睡眠状况有所改善.
- 两名患有复发性PFIC的兄弟姐妹在4个月内经历了改善的和睡眠.
- 两个完全失去胆盐出口 (BSEP) 蛋白质的兄弟姐妹没有反应,并接受了肝移植 (HCC,n=1;发育不良/,n=1).
- 四名患者报告过渡性腹部症状,随着剂量调整而消失;没有其他安全问题.
结论:
- 在这个现实世界队列中,奥德维克西巴特在大多数PFIC1和PFIC2患者中显示出临床益处.
- 在患有复发性PFIC的患者中,可能需要至少3个月的治疗时间来控制症状.
- 由于不一致的症状缓解,完全失去了BSEP的患者需要密切监测.
- 这项研究表明,奥德维克西巴特在现实世界PFIC管理中具有潜在的长期益处.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Diseases of the Liver and Gallbladder
429
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
429
Hepatic Drug Excretion: Influencing Factors
79
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
79
Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110
Chronic Pancreatitis I: Introduction
71
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
71
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93


